Page last updated: 2024-11-05

ethyl decanoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ethyl decanoate is an ester with the formula CH3(CH2)8CO2C2H5. It is a colorless liquid with a fruity odor. Ethyl decanoate is used as a flavoring agent in food and as a solvent in perfumes. It is also used as a plasticizer in plastics and as a lubricant. Ethyl decanoate is synthesized by the esterification of decanoic acid with ethanol. It is known to have some antifungal and antibacterial properties, and has been investigated for its potential use in cosmetics and personal care products. It is important for its pleasant odor and its ability to solubilize fragrances and other ingredients. Studies on ethyl decanoate focus on its potential uses in various fields, including food, cosmetics, and pharmaceuticals.'

ethyl decanoate : A fatty acid ethyl ester of decanoic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8048
CHEMBL ID3184829
CHEBI ID87430
SCHEMBL ID116995
MeSH IDM0242848

Synonyms (57)

Synonym
brn 1762128
capric acid ethyl ester
fema no. 2432
ethyl decanoate (natural)
nsc 8909
einecs 203-761-9
ai3-01976
decanoic acid, ethyl ester
nsc-8909
capric acid, ethyl ester
ethyl caprinate
110-38-3
wln: 9vo2
ethyl decanoate
nsc8909
ethyl caprate
ethyl decylate
ethyl decanoate, natural, >=98%, fcc, fg
ethyl decanoate, >=98%, fcc, fg
ethyl decanoate, reagentplus(r), >=99%
decanoic acid ethyl ester
D0022
A802183
NCGC00248319-01
we(2:0/10:0)
LMFA07010455
NCGC00255078-01
tox21_301180
dtxcid8024363
dtxsid0044363 ,
cas-110-38-3
unii-gy39fb86uo
gy39fb86uo ,
FT-0626169
AKOS009158697
SCHEMBL116995
ethyl n-decanoate
ethyl caprate [inci]
ethyl decanoate [fhfi]
ethyl decanoate [fcc]
ethyl caprate [mi]
ethyl ester of decanoic acid
n-capric acid ethyl ester
W-108688
chebi:87430 ,
CHEMBL3184829
mfcd00009581
ethyl decanoate, analytical standard
ethyl decanoate, vetec(tm) reagent grade, 98%
decanoic acid-ethyl ester
fema 2432
Q5404454
BS-14328
methyl2-([4-hydroxydihydro-2(3h)-isoxazolyl]carbonyl)benzenecarboxylate
CS-W015600
E83014
HY-W014884

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Absorption rate measurements were made from high vehicle volume (200 microliters/cm2) and low vehicle volume (< 10 microliters/cm2) applications."( Vehicle effects on in vitro percutaneous absorption through rat and human skin.
Auton, TR; Hilton, J; Scott, RC; Trebilcock, KL; Wilks, MF; Woollen, BH, 1994
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
fatty acid ethyl esterA fatty acid ester that is the carboxylic ester obtained by the formal condensation of a fatty acid with ethanol.
decanoate esterA fatty acid ester resulting from the formal condensation of the carboxy group of decanoic acid (capric acid) with the hydroxy group of an alcohol or phenol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency12.18470.000657.913322,387.1992AID1259377
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency30.60670.001022.650876.6163AID1224838
retinoid X nuclear receptor alphaHomo sapiens (human)Potency27.52230.000817.505159.3239AID1159531
estrogen nuclear receptor alphaHomo sapiens (human)Potency54.42730.000229.305416,493.5996AID743079
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency54.91410.001019.414170.9645AID743191
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1659751Agonist activity at TRPA1 (unknown origin) at 1000 uM relative to AITC2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Identification of a new class of non-electrophilic TRPA1 agonists by a structure-based virtual screening approach.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (7.14)18.2507
2000's3 (21.43)29.6817
2010's7 (50.00)24.3611
2020's3 (21.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.31 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index5.16 (4.65)
Search Engine Demand Index53.29 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]